TrovaGene, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 259 450 258 266
Cost of Revenue - - - -
Gross Profit 259 450 258 266
Operating Expenses
Research and Development 3,948 1,920 911 1,024
Sales, General and Admin. 7,002 3,379 2,324 1,954
Non-Recurring Items - - - 2,667
Other - - - -
Operating Income (10,691) (4,849) (2,977) (5,379)
Income From Continuing Operations
Add'l Income/Expense Items (1,103) (6,717) 794 46
Earnings Before Interest and Tax (11,794) (11,566) (2,806) (5,334)
Interest Expense 17 - 57 116
Earnings Before Tax (11,811) (11,566) (2,863) (5,449)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (11,811) (11,566) (2,239) (5,449)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (11,811) (11,566) (2,239) (5,449)
Preferred Stock and Other Adjustments (30) (38) (38) (38)
Net Income Applicable to Common Shareholders (11,841) (11,604) (2,277) (5,487)